TY - JOUR AU - Coiffier, B. AU - Lepage, E. AU - Briere, J. PY - 2002 DA - 2002// TI - CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011795 DO - 10.1056/NEJMoa011795 ID - Coiffier2002 ER - TY - JOUR AU - Pfreundschuh, M. AU - Kuhnt, E. AU - Trümper, L. PY - 2011 DA - 2011// TI - CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera international trial (MInT) group JO - The Lancet Oncology. VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70235-2 DO - 10.1016/S1470-2045(11)70235-2 ID - Pfreundschuh2011 ER - TY - STD TI - Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood. 2010;116:2040–2045. ID - ref3 ER - TY - JOUR AU - Gutiérrez, A. AU - Bento, L. AU - Bautista-Gili, A. M. PY - 2015 DA - 2015// TI - Differential impact of relative dose-intensity reductions in diffuse large B-cell lymphoma treated with R-CHOP21 or R-CHOP14 JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0123978 DO - 10.1371/journal.pone.0123978 ID - Gutiérrez2015 ER - TY - JOUR AU - Hirakawa, T. AU - Yamaguchi, H. AU - Yokose, N. PY - 2010 DA - 2010// TI - Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma JO - Ann Hematol VL - 89 UR - https://doi.org/10.1007/s00277-010-0956-7 DO - 10.1007/s00277-010-0956-7 ID - Hirakawa2010 ER - TY - JOUR AU - Terada, Y. AU - Nakamae, H. AU - Aimoto, R. PY - 2009 DA - 2009// TI - Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma JO - J Exp Clin Cancer Res VL - 28 UR - https://doi.org/10.1186/1756-9966-28-116 DO - 10.1186/1756-9966-28-116 ID - Terada2009 ER - TY - JOUR AU - Yamaguchi, H. AU - Hirakawa, T. AU - Inokuchi, K. PY - 2011 DA - 2011// TI - Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma JO - J Clin Exp Hematopathol VL - 51 UR - https://doi.org/10.3960/jslrt.51.1 DO - 10.3960/jslrt.51.1 ID - Yamaguchi2011 ER - TY - JOUR AU - Nebigil, C. G. AU - Désaubry, L. PY - 2018 DA - 2018// TI - Updates in Anthracycline-mediated Cardiotoxicity JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.01262 DO - 10.3389/fphar.2018.01262 ID - Nebigil2018 ER - TY - JOUR AU - Wojtacki, J. AU - Lewicka-Nowak, E. AU - Leśniewski-Kmak, K. PY - 2000 DA - 2000// TI - Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature JO - Med Sci Monit VL - 6 ID - Wojtacki2000 ER - TY - JOUR AU - Vejpongsa, P. AU - Yeh, E. T. H. PY - 2014 DA - 2014// TI - Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities JO - J Am Coll Cardiol VL - 64 UR - https://doi.org/10.1016/j.jacc.2014.06.1167 DO - 10.1016/j.jacc.2014.06.1167 ID - Vejpongsa2014 ER - TY - STD TI - Ng KH, Dearden C, Gruber P. Rituximab-induced Takotsubo syndrome: more cardiotoxic than it appears? Case Reports. 2015;2015:bcr2014208203–bcr2014208203. ID - ref11 ER - TY - JOUR AU - Foran, J. M. AU - Rohatiner, A. Z. AU - Cunningham, D. PY - 2000 DA - 2000// TI - European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.2.317 DO - 10.1200/JCO.2000.18.2.317 ID - Foran2000 ER - TY - JOUR AU - Castillo, J. J. AU - Ingham, R. R. AU - Reagan, J. L. PY - 2014 DA - 2014// TI - Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies JO - Clinical Lymphoma Myeloma and Leukemia VL - 14 UR - https://doi.org/10.1016/j.clml.2013.10.005 DO - 10.1016/j.clml.2013.10.005 ID - Castillo2014 ER - TY - JOUR AU - Braunwald, E. PY - 2008 DA - 2008// TI - Biomarkers in heart failure JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMra0800239 DO - 10.1056/NEJMra0800239 ID - Braunwald2008 ER - TY - JOUR AU - Boven, N. AU - Battes, L. C. AU - Akkerhuis, K. M. PY - 2018 DA - 2018// TI - Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the bio-SHiFT study JO - Am Heart J VL - 196 UR - https://doi.org/10.1016/j.ahj.2017.10.008 DO - 10.1016/j.ahj.2017.10.008 ID - Boven2018 ER - TY - JOUR AU - Maisel, A. AU - Mueller, C. AU - Adams, K. PY - 2008 DA - 2008// TI - State of the art: using natriuretic peptide levels in clinical practice JO - Eur J Heart Fail VL - 10 UR - https://doi.org/10.1016/j.ejheart.2008.07.014 DO - 10.1016/j.ejheart.2008.07.014 ID - Maisel2008 ER - TY - JOUR AU - Daugaard, G. AU - Lassen, U. AU - Bie, P. PY - 2005 DA - 2005// TI - Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction JO - Eur J Heart Fail VL - 7 UR - https://doi.org/10.1016/j.ejheart.2004.03.009 DO - 10.1016/j.ejheart.2004.03.009 ID - Daugaard2005 ER - TY - JOUR AU - Sawaya, H. AU - Sebag, I. A. AU - Plana, J. C. PY - 2011 DA - 2011// TI - Early detection and prediction of Cardiotoxicity in chemotherapy-treated patients JO - Am J Cardiol VL - 107 UR - https://doi.org/10.1016/j.amjcard.2011.01.006 DO - 10.1016/j.amjcard.2011.01.006 ID - Sawaya2011 ER - TY - JOUR AU - Cardinale, D. AU - Sandri, M. T. AU - Martinoni, A. PY - 2000 DA - 2000// TI - Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy JO - J Am Coll Cardiol VL - 36 UR - https://doi.org/10.1016/S0735-1097(00)00748-8 DO - 10.1016/S0735-1097(00)00748-8 ID - Cardinale2000 ER - TY - JOUR AU - Suzuki, T. AU - Hayashi, D. AU - Yamazaki, T. PY - 1998 DA - 1998// TI - Elevated B-type natriuretic peptide levels after anthracycline administration JO - Am Heart J VL - 136 UR - https://doi.org/10.1053/hj.1998.v136.89908 DO - 10.1053/hj.1998.v136.89908 ID - Suzuki1998 ER - TY - STD TI - Ferraro MP, Gimeno-Vazquez E, Subirana I, et al. Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification. Eur J Haematol. 2019;ejh.13234. ID - ref21 ER - TY - JOUR AU - Assarsson, E. AU - Lundberg, M. AU - Holmquist, G. PY - 2014 DA - 2014// TI - Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0095192 DO - 10.1371/journal.pone.0095192 ID - Assarsson2014 ER - TY - STD TI - Rullman E, Melin M, Mandić M, et al. Circulatory factors associated with function and prognosis in patients with severe heart failure. Clin Res Cardiol [Internet]. 2019 [cited 2020 May 6]; Available from: http://link.springer.com/https://doi.org/10.1007/s00392-019-01554-3. ID - ref23 ER - TY - JOUR AU - Brankovic, M. AU - Martijn Akkerhuis, K. AU - Mouthaan, H. PY - 2019 DA - 2019// TI - Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure JO - Int J Cardiol VL - 276 UR - https://doi.org/10.1016/j.ijcard.2018.08.001 DO - 10.1016/j.ijcard.2018.08.001 ID - Brankovic2019 ER - TY - JOUR AU - Berg, V. J. AU - Bouwens, E. AU - Umans, V. A. W. M. PY - 2019 DA - 2019// TI - Longitudinally measured fibrinolysis factors are strong predictors of clinical outcome in patients with chronic heart failure: the bio-SHiFT study JO - Thromb Haemost VL - 119 UR - https://doi.org/10.1055/s-0039-1696973 DO - 10.1055/s-0039-1696973 ID - Berg2019 ER - TY - JOUR AU - Stenemo, M. AU - Nowak, C. AU - Byberg, L. PY - 2018 DA - 2018// TI - Circulating proteins as predictors of incident heart failure in the elderly: circulating proteins as predictors of incident heart failure JO - Eur J Heart Fail VL - 20 UR - https://doi.org/10.1002/ejhf.980 DO - 10.1002/ejhf.980 ID - Stenemo2018 ER - TY - JOUR AU - Ong, K. L. AU - Chung, R. W. S. AU - Hui, N. PY - 2020 DA - 2020// TI - Usefulness of certain protein biomarkers for prediction of coronary heart disease JO - Am J Cardiol VL - 125 UR - https://doi.org/10.1016/j.amjcard.2019.11.016 DO - 10.1016/j.amjcard.2019.11.016 ID - Ong2020 ER - TY - JOUR AU - Glimelius, B. AU - Melin, B. AU - Enblad, G. PY - 2018 DA - 2018// TI - U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden JO - Acta Oncol VL - 57 UR - https://doi.org/10.1080/0284186X.2017.1337926 DO - 10.1080/0284186X.2017.1337926 ID - Glimelius2018 ER - TY - JOUR AU - Lind, L. AU - Elmståhl, S. AU - Bergman, E. PY - 2013 DA - 2013// TI - EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases JO - Eur J Epidemiol VL - 28 UR - https://doi.org/10.1007/s10654-013-9787-x DO - 10.1007/s10654-013-9787-x ID - Lind2013 ER - TY - JOUR PY - 1993 DA - 1993// TI - A predictive model for aggressive non-Hodgkin’s lymphoma JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309303291402 DO - 10.1056/NEJM199309303291402 ID - ref30 ER - TY - JOUR AU - Ziepert, M. AU - Hasenclever, D. AU - Kuhnt, E. PY - 2010 DA - 2010// TI - Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.2493 DO - 10.1200/JCO.2009.26.2493 ID - Ziepert2010 ER - TY - JOUR AU - Björk, J. AU - Grubb, A. AU - Sterner, G. PY - 2011 DA - 2011// TI - Revised equations for estimating glomerular filtration rate based on the Lund-Malmö study cohort JO - Scand J Clin Lab Invest VL - 71 UR - https://doi.org/10.3109/00365513.2011.557086 DO - 10.3109/00365513.2011.557086 ID - Björk2011 ER - TY - JOUR AU - Nyman, U. AU - Grubb, A. AU - Larsson, A. PY - 2014 DA - 2014// TI - The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population JO - Clin Chem Lab Med VL - 52 UR - https://doi.org/10.1515/cclm-2013-0741 DO - 10.1515/cclm-2013-0741 ID - Nyman2014 ER - TY - STD TI - Klimczak-Tomaniak D, Bouwens E, Schuurman A-S, et al. Temporal patterns of macrophage- and neutrophil-related markers are associated with clinical outcome in heart failure patients. ESC Heart Fail. 2020; ID - ref34 ER - TY - STD TI - Dubin RF, Whooley M, Pico A, et al. Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study. Shimosawa T, editor. PLoS ONE. 2018;13:e0208042. ID - ref35 ER - TY - JOUR AU - Qian, W. AU - Zhao, C. AU - Li, D. PY - 2018 DA - 2018// TI - Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury JO - Archives of Cardiovascular Diseases VL - 111 UR - https://doi.org/10.1016/j.acvd.2017.12.006 DO - 10.1016/j.acvd.2017.12.006 ID - Qian2018 ER - TY - JOUR AU - Zhu, J. AU - Zhang, J. AU - Zhang, L. PY - 2011 DA - 2011// TI - Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity JO - Biomed Pharmacother VL - 65 UR - https://doi.org/10.1016/j.biopha.2011.06.005 DO - 10.1016/j.biopha.2011.06.005 ID - Zhu2011 ER - TY - STD TI - Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus [Internet]. 2020 [cited 2020 Aug 31]; Available from: https://www.cureus.com/articles/36728-global-epidemiology-of-ischemic-heart-disease-results-from-the-global-burden-of-disease-study. UR - https://www.cureus.com/articles/36728-global-epidemiology-of-ischemic-heart-disease-results-from-the-global-burden-of-disease-study ID - ref38 ER - TY - STD TI - Larsson K, Mattsson M, Ebrahim F, et al. High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study. Br J Haematol [Internet]. 2020 [cited 2020 Aug 31];190. Available from: https://onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1111/bjh.16859. ID - ref39 ER - TY - JOUR AU - Limat, S. AU - Demesmay, K. AU - Voillat, L. PY - 2003 DA - 2003// TI - Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg070 DO - 10.1093/annonc/mdg070 ID - Limat2003 ER - TY - JOUR AU - Hequet, O. AU - Le, Q. H. AU - Moullet, I. PY - 2004 DA - 2004// TI - Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults JO - JCO. VL - 22 UR - https://doi.org/10.1200/JCO.2004.06.033 DO - 10.1200/JCO.2004.06.033 ID - Hequet2004 ER - TY - JOUR AU - Moser, E. C. PY - 2006 DA - 2006// TI - Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma JO - Blood. VL - 107 UR - https://doi.org/10.1182/blood-2005-08-3392 DO - 10.1182/blood-2005-08-3392 ID - Moser2006 ER - TY - JOUR AU - Lotrionte, M. AU - Biondi-Zoccai, G. AU - Abbate, A. PY - 2013 DA - 2013// TI - Review and meta-analysis of incidence and clinical predictors of Anthracycline Cardiotoxicity JO - Am J Cardiol VL - 112 UR - https://doi.org/10.1016/j.amjcard.2013.08.026 DO - 10.1016/j.amjcard.2013.08.026 ID - Lotrionte2013 ER -